( 0 1 0 1 O
Bacillus 1 9 1 9 B-chronic_disease
tuberculosis 10 22 10 22 I-chronic_disease
) 22 23 22 23 O

Absolute 0 8 24 32 B-clinical_variable
neutrophil 9 19 33 43 I-clinical_variable
count 20 25 44 49 I-clinical_variable
( 26 27 50 51 I-clinical_variable
ANC 27 30 51 54 I-clinical_variable
) 30 31 54 55 I-clinical_variable
> 32 33 56 57 O
= 33 34 57 58 O
1,500 35 40 59 64 B-lower_bound
/mcL 41 45 65 69 I-lower_bound

Active 0 6 70 76 O
autoimmune 7 17 77 87 B-chronic_disease
disease 18 25 88 95 I-chronic_disease
that 26 30 96 100 O
has 31 34 101 104 O
required 35 43 105 113 O
systemic 44 52 114 122 B-treatment
treatment 53 62 123 132 I-treatment
in 63 65 133 135 O
the 66 69 136 139 O
past 70 74 140 144 B-upper_bound
2 75 76 145 146 I-upper_bound
years 77 82 147 152 I-upper_bound
( 83 84 153 154 O
i.e. 84 88 154 158 O
with 89 93 159 163 O
use 94 97 164 167 O
of 98 100 168 170 O
disease 101 108 171 178 B-treatment
modifying 109 118 179 188 I-treatment
agents 119 125 189 195 I-treatment
, 125 126 195 196 O
corticosteroids 127 142 197 212 B-treatment
or 143 145 213 215 O
immunosuppressive 146 163 216 233 B-treatment
drugs 164 169 234 239 I-treatment
) 169 170 239 240 O
; 170 171 240 241 O
replacement 172 183 242 253 B-treatment
therapy 184 191 254 261 I-treatment
( 192 193 262 263 O
eg 193 195 263 265 O
. 195 196 265 266 O
, 196 197 266 267 O
thyroxine 198 207 268 277 B-treatment
, 207 208 277 278 O
insulin 209 216 279 286 B-treatment
, 216 217 286 287 O
or 218 220 288 290 O
physiologic 221 232 291 302 B-treatment
corticosteroid 233 247 303 317 I-treatment
replacement 248 259 318 329 I-treatment
therapy 260 267 330 337 I-treatment
for 268 271 338 341 O
adrenal 272 279 342 349 B-chronic_disease
or 280 282 350 352 O
pituitary 283 292 353 362 B-chronic_disease
insufficiency 293 306 363 376 I-chronic_disease
, 306 307 376 377 O
etc 308 311 378 381 O
. 311 312 381 382 O
) 312 313 382 383 O
is 314 316 384 386 O
not 317 320 387 390 O
considered 321 331 391 401 O
a 332 333 402 403 O
form 334 338 404 408 O
of 339 341 409 411 O
systemic 342 350 412 420 O
treatment 351 360 421 430 O

Active 0 6 431 437 B-chronic_disease
infection 7 16 438 447 I-chronic_disease
requiring 17 26 448 457 O
systemic 27 35 458 466 B-treatment
therapy 36 43 467 474 I-treatment

Albumin 0 7 475 482 B-clinical_variable
> 8 9 483 484 O
= 9 10 484 485 O
2.5 11 14 486 489 B-lower_bound
mg 15 17 490 492 I-lower_bound
/ 17 18 492 493 I-lower_bound
dL 18 20 493 495 I-lower_bound

Anti 0 4 496 500 B-treatment
- 4 5 500 501 I-treatment
cancer 5 11 501 507 I-treatment
monoclonal 12 22 508 518 I-treatment
antibody 23 31 519 527 I-treatment
( 32 33 528 529 I-treatment
mAb 33 36 529 532 I-treatment
) 36 37 532 533 I-treatment
within 38 44 534 540 O
4 45 46 541 542 B-lower_bound
weeks 47 52 543 548 I-lower_bound
prior 53 58 549 554 I-upper_bound
to 59 61 555 557 O
study 62 67 558 563 O
day 68 71 564 567 O
1 72 73 568 569 O
or 74 76 570 572 O
who 77 80 573 576 O
has 81 84 577 580 O
not 85 88 581 584 O
recovered 89 98 585 594 O
( 99 100 595 596 O
i.e. 100 104 596 600 O
, 104 105 600 601 O
= 106 107 602 603 O
< 107 108 603 604 O
grade 109 114 605 610 B-upper_bound
1 115 116 611 612 I-upper_bound
or 117 119 613 615 O
at 120 122 616 618 O
baseline 123 131 619 627 O
) 131 132 627 628 O
from 133 137 629 633 O
adverse 138 145 634 641 O
events 146 152 642 648 O
due 153 156 649 652 O
to 157 159 653 655 O
agents 160 166 656 662 O
administered 167 179 663 675 O
more 180 184 676 680 O
than 185 189 681 685 O
4 190 191 686 687 O
weeks 192 197 688 693 O
earlier 198 205 694 701 O

Aspartate 0 9 702 711 B-clinical_variable
aminotransferase 10 26 712 728 I-clinical_variable
( 27 28 729 730 I-clinical_variable
AST 28 31 730 733 I-clinical_variable
) 31 32 733 734 I-clinical_variable
( 33 34 735 736 O
serum 34 39 736 741 B-clinical_variable
glutamic 40 48 742 750 I-clinical_variable
oxaloacetic 49 60 751 762 I-clinical_variable
transaminase 61 73 763 775 I-clinical_variable
[ 74 75 776 777 I-clinical_variable
SGOT 75 79 777 781 I-clinical_variable
] 79 80 781 782 I-clinical_variable
) 80 81 782 783 O
and 82 85 784 787 O
alanine 86 93 788 795 B-clinical_variable
aminotransferase 94 110 796 812 I-clinical_variable
( 111 112 813 814 I-clinical_variable
ALT 112 115 814 817 I-clinical_variable
) 115 116 817 818 I-clinical_variable
( 117 118 819 820 O
serum 118 123 820 825 B-clinical_variable
glutamate 124 133 826 835 I-clinical_variable
pyruvate 134 142 836 844 I-clinical_variable
transaminase 143 155 845 857 I-clinical_variable
[ 156 157 858 859 I-clinical_variable
SGPT 157 161 859 863 I-clinical_variable
] 161 162 863 864 I-clinical_variable
) 162 163 864 865 O
= 164 165 866 867 O
< 165 166 867 868 O
2.5 167 170 869 872 B-upper_bound
X 171 172 873 874 I-upper_bound
ULN 173 176 875 878 I-upper_bound
OR 177 179 879 881 O
= 180 181 882 883 O
< 181 182 883 884 O
5 183 184 885 886 O
X 185 186 887 888 O
ULN 187 190 889 892 O
for 191 194 893 896 O
subjects 195 203 897 905 O
with 204 208 906 910 O
liver 209 214 911 916 B-cancer
metastases 215 225 917 927 I-cancer

At 0 2 928 930 O
least 3 8 931 936 O
1 9 10 937 938 B-lower_bound
prior 11 16 939 944 B-treatment
chemotherapy 17 29 945 957 I-treatment
regimen 30 37 958 965 I-treatment
containing 38 48 966 976 I-treatment
cisplatin 49 58 977 986 I-treatment
or 59 61 987 989 O
carboplatin 62 73 990 1001 B-treatment

Chemotherapy 0 12 1002 1014 B-treatment
, 12 13 1014 1015 O
targeted 14 22 1016 1024 B-treatment
small 23 28 1025 1030 I-treatment
molecule 29 37 1031 1039 I-treatment
therapy 38 45 1040 1047 I-treatment
, 45 46 1047 1048 O
or 47 49 1049 1051 O
radiation 50 59 1052 1061 B-treatment
therapy 60 67 1062 1069 I-treatment
within 68 74 1070 1076 O
2 75 76 1077 1078 B-upper_bound
weeks 77 82 1079 1084 I-upper_bound
prior 83 88 1085 1090 I-upper_bound
to 89 91 1091 1093 O
study 92 97 1094 1099 O
day 98 101 1100 1103 O
1 102 103 1104 1105 O
or 104 106 1106 1108 O
who 107 110 1109 1112 O
has 111 114 1113 1116 O
not 115 118 1117 1120 O
recovered 119 128 1121 1130 O
( 129 130 1131 1132 O
i.e. 130 134 1132 1136 O
, 134 135 1136 1137 O
= 136 137 1138 1139 O
< 137 138 1139 1140 O
grade 139 144 1141 1146 B-upper_bound
1 145 146 1147 1148 I-upper_bound
or 147 149 1149 1151 O
at 150 152 1152 1154 O
baseline 153 161 1155 1163 O
) 161 162 1163 1164 O
from 163 167 1165 1169 O
adverse 168 175 1170 1177 O
events 176 182 1178 1184 O
due 183 186 1185 1188 O
to 187 189 1189 1191 O
a 190 191 1192 1193 O
previously 192 202 1194 1204 O
administered 203 215 1205 1217 O
agent 216 221 1218 1223 O

Currently 0 9 1224 1233 O
receiving 10 19 1234 1243 O
or 20 22 1244 1246 O
has 23 26 1247 1250 O
had 27 30 1251 1254 O
treatment 31 40 1255 1264 B-treatment
with 41 45 1265 1269 O
an 46 48 1270 1272 O
investigational 49 64 1273 1288 B-treatment
agent 65 70 1289 1294 I-treatment
or 71 73 1295 1297 O
used 74 78 1298 1302 O
an 79 81 1303 1305 O
investigational 82 97 1306 1321 B-treatment
device 98 104 1322 1328 I-treatment
within 105 111 1329 1335 O
4 112 113 1336 1337 B-upper_bound
weeks 114 119 1338 1343 I-upper_bound
of 120 122 1344 1346 O
study 123 128 1347 1352 O
day 129 132 1353 1356 O
1 133 134 1357 1358 O

Diagnosis 0 9 1359 1368 O
of 10 12 1369 1371 O
immunodeficiency 13 29 1372 1388 B-chronic_disease
or 30 32 1389 1391 O
is 33 35 1392 1394 O
receiving 36 45 1395 1404 O
systemic 46 54 1405 1413 B-treatment
steroid 55 62 1414 1421 I-treatment
therapy 63 70 1422 1429 I-treatment
or 71 73 1430 1432 O
any 74 77 1433 1436 O
other 78 83 1437 1442 O
form 84 88 1443 1447 O
of 89 91 1448 1450 O
immunosuppressive 92 109 1451 1468 B-treatment
therapy 110 117 1469 1476 I-treatment
within 118 124 1477 1483 O
7 125 126 1484 1485 B-upper_bound
days 127 131 1486 1490 I-upper_bound
prior 132 137 1491 1496 I-upper_bound
to 138 140 1497 1499 O
the 141 144 1500 1503 O
first 145 150 1504 1509 O
dose 151 155 1510 1514 O
of 156 158 1515 1517 O
trial 159 164 1518 1523 B-treatment
treatment 165 174 1524 1533 I-treatment

Female 0 6 1534 1540 B-gender
subjects 7 15 1541 1549 I-gender
of 16 18 1550 1552 O
childbearing 19 31 1553 1565 O
potential 32 41 1566 1575 O
should 42 48 1576 1582 O
be 49 51 1583 1585 O
willing 52 59 1586 1593 B-contraception_consent
to 60 62 1594 1596 I-contraception_consent
use 63 66 1597 1600 I-contraception_consent
2 67 68 1601 1602 I-contraception_consent
methods 69 76 1603 1610 I-contraception_consent
of 77 79 1611 1613 I-contraception_consent
birth 80 85 1614 1619 I-contraception_consent
control 86 93 1620 1627 I-contraception_consent
or 94 96 1628 1630 I-contraception_consent
be 97 99 1631 1633 I-contraception_consent
surgically 100 110 1634 1644 I-contraception_consent
sterile 111 118 1645 1652 I-contraception_consent
, 118 119 1652 1653 O
or 120 122 1654 1656 O
abstain 123 130 1657 1664 O
from 131 135 1665 1669 O
heterosexual 136 148 1670 1682 O
activity 149 157 1683 1691 O
for 158 161 1692 1695 O
the 162 165 1696 1699 O
course 166 172 1700 1706 O
of 173 175 1707 1709 O
the 176 179 1710 1713 O
study 180 185 1714 1719 O
through 186 193 1720 1727 O
120 194 197 1728 1731 B-upper_bound
days 198 202 1732 1736 I-upper_bound
after 203 208 1737 1742 I-upper_bound
the 209 212 1743 1746 O
last 213 217 1747 1751 O
dose 218 222 1752 1756 O
of 223 225 1757 1759 O
study 226 231 1760 1765 O
medication 232 242 1766 1776 B-treatment
; 242 243 1776 1777 O
subjects 244 252 1778 1786 O
of 253 255 1787 1789 O
childbearing 256 268 1790 1802 O
potential 269 278 1803 1812 O
are 279 282 1813 1816 O
those 283 288 1817 1822 O
who 289 292 1823 1826 O
have 293 297 1827 1831 O
not 298 301 1832 1835 O
been 302 306 1836 1840 O
surgically 307 317 1841 1851 O
sterilized 318 328 1852 1862 O
or 329 331 1863 1865 O
have 332 336 1866 1870 O
not 337 340 1871 1874 O
been 341 345 1875 1879 O
free 346 350 1880 1884 O
from 351 355 1885 1889 O
menses 356 362 1890 1896 O
for 363 366 1897 1900 O
> 367 368 1901 1902 O
1 369 370 1903 1904 B-lower_bound
year 371 375 1905 1909 I-lower_bound

Hemoglobin 0 10 1910 1920 B-clinical_variable
> 11 12 1921 1922 O
= 12 13 1922 1923 O
9 14 15 1924 1925 B-lower_bound
g 16 17 1926 1927 I-lower_bound
/ 17 18 1927 1928 I-lower_bound
dL 18 20 1928 1930 I-lower_bound
without 21 28 1931 1938 O
transfusion 29 40 1939 1950 O
dependency 41 51 1951 1961 O

History 0 7 1962 1969 O
or 8 10 1970 1972 O
current 11 18 1973 1980 O
evidence 19 27 1981 1989 O
of 28 30 1990 1992 O
any 31 34 1993 1996 O
condition 35 44 1997 2006 O
, 44 45 2006 2007 O
therapy 46 53 2008 2015 B-treatment
, 53 54 2015 2016 O
or 55 57 2017 2019 O
laboratory 58 68 2020 2030 O
abnormality 69 80 2031 2042 O
that 81 85 2043 2047 O
might 86 91 2048 2053 O
confound 92 100 2054 2062 O
the 101 104 2063 2066 O
results 105 112 2067 2074 O
of 113 115 2075 2077 O
the 116 119 2078 2081 O
trial 120 125 2082 2087 O
, 125 126 2087 2088 O
interfere 127 136 2089 2098 O
with 137 141 2099 2103 O
the 142 145 2104 2107 O
subject 146 153 2108 2115 O
's 153 155 2115 2117 O
participation 156 169 2118 2131 O
for 170 173 2132 2135 O
the 174 177 2136 2139 O
full 178 182 2140 2144 O
duration 183 191 2145 2153 O
of 192 194 2154 2156 O
the 195 198 2157 2160 O
trial 199 204 2161 2166 O
, 204 205 2166 2167 O
or 206 208 2168 2170 O
is 209 211 2171 2173 O
not 212 215 2174 2177 O
in 216 218 2178 2180 O
the 219 222 2181 2184 O
best 223 227 2185 2189 O
interest 228 236 2190 2198 O
of 237 239 2199 2201 O
the 240 243 2202 2205 O
subject 244 251 2206 2213 O
to 252 254 2214 2216 O
participate 255 266 2217 2228 O

Hypersensitivity 0 16 2229 2245 O
to 17 19 2246 2248 O
pembrolizumab 20 33 2249 2262 B-allergy_name
, 33 34 2262 2263 O
any 35 38 2264 2267 O
of 39 41 2268 2270 O
its 42 45 2271 2274 O
excipients 46 56 2275 2285 B-treatment
, 56 57 2285 2286 O
paclitaxel 58 68 2287 2297 B-treatment
, 68 69 2297 2298 O
or 70 72 2299 2301 O
any 73 76 2302 2305 O
of 77 79 2306 2308 O
its 80 83 2309 2312 O
excipients 84 94 2313 2323 O

Known 0 5 2324 2329 O
active 6 12 2330 2336 O
central 13 20 2337 2344 B-cancer
nervous 21 28 2345 2352 I-cancer
system 29 35 2353 2359 I-cancer
( 36 37 2360 2361 I-cancer
CNS 37 40 2361 2364 I-cancer
) 40 41 2364 2365 I-cancer
metastases 42 52 2366 2376 I-cancer
and/or 53 59 2377 2383 O
carcinomatous 60 73 2384 2397 B-cancer
meningitis 74 84 2398 2408 I-cancer
; 84 85 2408 2409 O
subjects 86 94 2410 2418 O
with 95 99 2419 2423 O
previously 100 110 2424 2434 O
treated 111 118 2435 2442 O
brain 119 124 2443 2448 B-cancer
metastases 125 135 2449 2459 I-cancer
may 136 139 2460 2463 O
participate 140 151 2464 2475 O
provided 152 160 2476 2484 O
they 161 165 2485 2489 O
are 166 169 2490 2493 O
stable 170 176 2494 2500 O
( 177 178 2501 2502 O
without 178 185 2502 2509 O
evidence 186 194 2510 2518 O
of 195 197 2519 2521 O
progression 198 209 2522 2533 O
by 210 212 2534 2536 O
imaging 213 220 2537 2544 O
for 221 224 2545 2548 O
at 225 227 2549 2551 O
least 228 233 2552 2557 O
four 234 238 2558 2562 B-lower_bound
weeks 239 244 2563 2568 I-lower_bound
prior 245 250 2569 2574 I-lower_bound
to 251 253 2575 2577 O
the 254 257 2578 2581 O
first 258 263 2582 2587 O
dose 264 268 2588 2592 O
of 269 271 2593 2595 O
trial 272 277 2596 2601 B-treatment
treatment 278 287 2602 2611 I-treatment
and 288 291 2612 2615 O
any 292 295 2616 2619 O
neurologic 296 306 2620 2630 O
symptoms 307 315 2631 2639 O
have 316 320 2640 2644 O
returned 321 329 2645 2653 O
to 330 332 2654 2656 O
baseline 333 341 2657 2665 O
) 341 342 2665 2666 O
, 342 343 2666 2667 O
have 344 348 2668 2672 O
no 349 351 2673 2675 O
evidence 352 360 2676 2684 O
of 361 363 2685 2687 O
new 364 367 2688 2691 O
or 368 370 2692 2694 O
enlarging 371 380 2695 2704 O
brain 381 386 2705 2710 O
metastases 387 397 2711 2721 O
, 397 398 2721 2722 O
and 399 402 2723 2726 O
are 403 406 2727 2730 O
not 407 410 2731 2734 O
using 411 416 2735 2740 O
steroids 417 425 2741 2749 B-treatment
for 426 429 2750 2753 O
at 430 432 2754 2756 O
least 433 438 2757 2762 O
7 439 440 2763 2764 B-lower_bound
days 441 445 2765 2769 I-lower_bound
prior 446 451 2770 2775 I-lower_bound
to 452 454 2776 2778 O
trial 455 460 2779 2784 O
treatment 461 470 2785 2794 O
; 470 471 2794 2795 O
this 472 476 2796 2800 O
exception 477 486 2801 2810 O
does 487 491 2811 2815 O
not 492 495 2816 2819 O
include 496 503 2820 2827 O
carcinomatous 504 517 2828 2841 O
meningitis 518 528 2842 2852 O
which 529 534 2853 2858 O
is 535 537 2859 2861 O
excluded 538 546 2862 2870 O
regardless 547 557 2871 2881 O
of 558 560 2882 2884 O
clinical 561 569 2885 2893 O
stability 570 579 2894 2903 O

Known 0 5 2904 2909 O
active 6 12 2910 2916 B-chronic_disease
hepatitis 13 22 2917 2926 I-chronic_disease
B 23 24 2927 2928 I-chronic_disease
( 25 26 2929 2930 O
e.g. 26 30 2930 2934 O
, 30 31 2934 2935 O
hepatitis 32 41 2936 2945 O
B 42 43 2946 2947 O
virus 44 49 2948 2953 O
surface 50 57 2954 2961 O
antigen 58 65 2962 2969 O
[ 66 67 2970 2971 O
HBsAg 67 72 2971 2976 O
] 72 73 2976 2977 O
reactive 74 82 2978 2986 O
) 82 83 2986 2987 O
or 84 86 2988 2990 O
hepatitis 87 96 2991 3000 B-chronic_disease
C 97 98 3001 3002 I-chronic_disease
( 99 100 3003 3004 O
e.g. 100 104 3004 3008 O
, 104 105 3008 3009 O
hepatitis 106 115 3010 3019 O
C 116 117 3020 3021 O
virus 118 123 3022 3027 O
[ 124 125 3028 3029 O
HCV 125 128 3029 3032 O
] 128 129 3032 3033 O
ribonucleic 130 141 3034 3045 O
acid 142 146 3046 3050 O
[ 147 148 3051 3052 O
RNA 148 151 3052 3055 O
] 151 152 3055 3056 O
[ 153 154 3057 3058 O
qualitative 154 165 3058 3069 O
] 165 166 3069 3070 O
is 167 169 3071 3073 O
detected 170 178 3074 3082 O
) 178 179 3082 3083 O

Known 0 5 3084 3089 O
additional 6 16 3090 3100 O
malignancy 17 27 3101 3111 B-cancer
that 28 32 3112 3116 O
is 33 35 3117 3119 O
progressing 36 47 3120 3131 O
or 48 50 3132 3134 O
requires 51 59 3135 3143 O
active 60 66 3144 3150 B-treatment
treatment 67 76 3151 3160 I-treatment
; 76 77 3160 3161 O
exceptions 78 88 3162 3172 O
include 89 96 3173 3180 O
basal 97 102 3181 3186 B-cancer
cell 103 107 3187 3191 I-cancer
carcinoma 108 117 3192 3201 I-cancer
of 118 120 3202 3204 O
the 121 124 3205 3208 O
skin 125 129 3209 3213 O
or 130 132 3214 3216 O
squamous 133 141 3217 3225 B-cancer
cell 142 146 3226 3230 I-cancer
carcinoma 147 156 3231 3240 I-cancer
of 157 159 3241 3243 O
the 160 163 3244 3247 O
skin 164 168 3248 3252 O
that 169 173 3253 3257 O
has 174 177 3258 3261 O
undergone 178 187 3262 3271 O
potentially 188 199 3272 3283 O
curative 200 208 3284 3292 B-treatment
therapy 209 216 3293 3300 I-treatment
or 217 219 3301 3303 O
in 220 222 3304 3306 B-cancer
situ 223 227 3307 3311 I-cancer
cervical 228 236 3312 3320 I-cancer
cancer 237 243 3321 3327 I-cancer

Known 0 5 3328 3333 O
history 6 13 3334 3341 O
of 14 16 3342 3344 O
active 17 23 3345 3351 B-chronic_disease
TB 24 26 3352 3354 I-chronic_disease

Known 0 5 3355 3360 O
history 6 13 3361 3368 O
of 14 16 3369 3371 O
human 17 22 3372 3377 B-chronic_disease
immunodeficiency 23 39 3378 3394 I-chronic_disease
virus 40 45 3395 3400 I-chronic_disease
( 46 47 3401 3402 I-chronic_disease
HIV 47 50 3402 3405 I-chronic_disease
) 50 51 3405 3406 I-chronic_disease
( 52 53 3407 3408 O
HIV 53 56 3408 3411 O
1/2 57 60 3412 3415 O
antibodies 61 71 3416 3426 O
) 71 72 3426 3427 O

Known 0 5 3428 3433 O
history 6 13 3434 3441 O
of 14 16 3442 3444 O
, 16 17 3444 3445 O
or 18 20 3446 3448 O
any 21 24 3449 3452 O
evidence 25 33 3453 3461 O
of 34 36 3462 3464 O
active 37 43 3465 3471 B-chronic_disease
, 43 44 3471 3472 O
non 45 48 3473 3476 B-chronic_disease
- 48 49 3476 3477 I-chronic_disease
infectious 49 59 3477 3487 I-chronic_disease
pneumonitis 60 71 3488 3499 I-chronic_disease

Known 0 5 3500 3505 O
psychiatric 6 17 3506 3517 B-chronic_disease
or 18 20 3518 3520 O
substance 21 30 3521 3530 O
abuse 31 36 3531 3536 O
disorders 37 46 3537 3546 O
that 47 51 3547 3551 O
would 52 57 3552 3557 O
interfere 58 67 3558 3567 O
with 68 72 3568 3572 O
cooperation 73 84 3573 3584 O
with 85 89 3585 3589 O
the 90 93 3590 3593 O
requirements 94 106 3594 3606 O
of 107 109 3607 3609 O
the 110 113 3610 3613 O
trial 114 119 3614 3619 O

Male 0 4 3620 3624 B-gender
subjects 5 13 3625 3633 I-gender
should 14 20 3634 3640 O
agree 21 26 3641 3646 B-contraception_consent
to 27 29 3647 3649 I-contraception_consent
use 30 33 3650 3653 I-contraception_consent
an 34 36 3654 3656 I-contraception_consent
adequate 37 45 3657 3665 I-contraception_consent
method 46 52 3666 3672 I-contraception_consent
of 53 55 3673 3675 I-contraception_consent
contraception 56 69 3676 3689 I-contraception_consent
starting 70 78 3690 3698 O
with 79 83 3699 3703 O
the 84 87 3704 3707 O
first 88 93 3708 3713 O
dose 94 98 3714 3718 O
of 99 101 3719 3721 O
study 102 107 3722 3727 O
therapy 108 115 3728 3735 B-treatment
through 116 123 3736 3743 O
120 124 127 3744 3747 B-upper_bound
days 128 132 3748 3752 I-upper_bound
after 133 138 3753 3758 I-upper_bound
the 139 142 3759 3762 O
last 143 147 3763 3767 O
dose 148 152 3768 3772 O
of 153 155 3773 3775 O
study 156 161 3776 3781 O
therapy 162 169 3782 3789 O

Patient 0 7 3790 3797 O
must 8 12 3798 3802 O
be 13 15 3803 3805 O
willing 16 23 3806 3813 O
to 24 26 3814 3816 O
provide 27 34 3817 3824 O
tissue 35 41 3825 3831 O
from 42 46 3832 3836 O
a 47 48 3837 3838 O
newly 49 54 3839 3844 O
obtained 55 63 3845 3853 O
core 64 68 3854 3858 B-treatment
or 69 71 3859 3861 O
excisional 72 82 3862 3872 B-treatment
biopsy 83 89 3873 3879 I-treatment
of 90 92 3880 3882 O
a 93 94 3883 3884 O
tumor 95 100 3885 3890 B-cancer
lesion 101 107 3891 3897 I-cancer
; 107 108 3897 3898 O
newly 109 114 3899 3904 O
- 114 115 3904 3905 O
obtained 115 123 3905 3913 O
is 124 126 3914 3916 O
defined 127 134 3917 3924 O
as 135 137 3925 3927 O
a 138 139 3928 3929 O
specimen 140 148 3930 3938 O
obtained 149 157 3939 3947 O
up 158 160 3948 3950 O
to 161 163 3951 3953 O
12 164 166 3954 3956 B-upper_bound
weeks 167 172 3957 3962 I-upper_bound
( 173 174 3963 3964 O
84 174 176 3964 3966 O
days 177 181 3967 3971 O
) 181 182 3971 3972 O
prior 183 188 3973 3978 O
to 189 191 3979 3981 O
initiation 192 202 3982 3992 O
of 203 205 3993 3995 O
treatment 206 215 3996 4005 B-treatment
on 216 218 4006 4008 O
day 219 222 4009 4012 O
1 223 224 4013 4014 O
; 224 225 4014 4015 O
archived 226 234 4016 4024 O
specimen 235 243 4025 4033 O
can 244 247 4034 4037 O
be 248 250 4038 4040 O
used 251 255 4041 4045 O
for 256 259 4046 4049 O
subjects 260 268 4050 4058 O
in 269 271 4059 4061 O
whom 272 276 4062 4066 O
newly 277 282 4067 4072 O
- 282 283 4072 4073 O
obtained 283 291 4073 4081 O
samples 292 299 4082 4089 O
can 300 303 4090 4093 O
not 303 306 4093 4096 O
be 307 309 4097 4099 O
provided 310 318 4100 4108 O

Patients 0 8 4109 4117 O
diagnosed 9 18 4118 4127 O
with 19 23 4128 4132 O
platinum 24 32 4133 4141 B-cancer
- 32 33 4141 4142 I-cancer
refractory 33 43 4142 4152 I-cancer
metastatic 44 54 4153 4163 I-cancer
urothelial 55 65 4164 4174 I-cancer
cancer 66 72 4175 4181 I-cancer
that 73 77 4182 4186 O
is 78 80 4187 4189 O
measureable 81 92 4190 4201 O
based 93 98 4202 4207 O
on 99 101 4208 4210 O
Response 102 110 4211 4219 O
Evaluation 111 121 4220 4230 O
Criteria 122 130 4231 4239 O
in 131 133 4240 4242 O
Solid 134 139 4243 4248 O
Tumors 140 146 4249 4255 O
( 147 148 4256 4257 O
RECIST 148 154 4257 4263 O
) 154 155 4263 4264 O
criteria 156 164 4265 4273 O
1.1 165 168 4274 4277 O

Performance 0 11 4278 4289 B-clinical_variable
status 12 18 4290 4296 I-clinical_variable
of 19 21 4297 4299 O
0 22 23 4300 4301 B-lower_bound
or 24 26 4302 4304 O
1 27 28 4305 4306 B-upper_bound
on 29 31 4307 4309 O
the 32 35 4310 4313 O
Eastern 36 43 4314 4321 B-clinical_variable
Cooperative 44 55 4322 4333 I-clinical_variable
Oncology 56 64 4334 4342 I-clinical_variable
Group 65 70 4343 4348 I-clinical_variable
( 71 72 4349 4350 I-clinical_variable
ECOG 72 76 4350 4354 I-clinical_variable
) 76 77 4354 4355 I-clinical_variable
performance 78 89 4356 4367 I-clinical_variable
scale 90 95 4368 4373 I-clinical_variable

Platelets 0 9 4374 4383 B-clinical_variable
> 10 11 4384 4385 O
= 11 12 4385 4386 O
80,000 13 19 4387 4393 B-lower_bound
/ 20 21 4394 4395 I-lower_bound
mcL 22 25 4396 4399 I-lower_bound

Pregnancy 0 9 4400 4409 B-pregnancy
or 10 12 4410 4412 O
breastfeeding 13 26 4413 4426 O
, 26 27 4426 4427 O
or 28 30 4428 4430 O
expecting 31 40 4431 4440 O
to 41 43 4441 4443 O
conceive 44 52 4444 4452 O
or 53 55 4453 4455 O
father 56 62 4456 4462 O
children 63 71 4463 4471 O
within 72 78 4472 4478 O
the 79 82 4479 4482 O
projected 83 92 4483 4492 O
duration 93 101 4493 4501 O
of 102 104 4502 4504 O
the 105 108 4505 4508 O
trial 109 114 4509 4514 O
, 114 115 4514 4515 O
starting 116 124 4516 4524 O
with 125 129 4525 4529 O
the 130 133 4530 4533 O
pre 134 137 4534 4537 O
- 137 138 4537 4538 O
screening 138 147 4538 4547 O
or 148 150 4548 4550 O
screening 151 160 4551 4560 O
visit 161 166 4561 4566 O
through 167 174 4567 4574 O
120 175 178 4575 4578 B-upper_bound
days 179 183 4579 4583 I-upper_bound
after 184 189 4584 4589 O
the 190 193 4590 4593 O
last 194 198 4594 4598 O
dose 199 203 4599 4603 O
of 204 206 4604 4606 O
trial 207 212 4607 4612 B-treatment
treatment 213 222 4613 4622 I-treatment

Prior 0 5 4623 4628 B-treatment
therapy 6 13 4629 4636 I-treatment
with 14 18 4637 4641 I-treatment
an 19 21 4642 4644 I-treatment
anti 22 26 4645 4649 I-treatment
- 26 27 4649 4650 I-treatment
programmed 27 37 4650 4660 I-treatment
cell 38 42 4661 4665 I-treatment
death 43 48 4666 4671 I-treatment
1 49 50 4672 4673 I-treatment
( 51 52 4674 4675 I-treatment
PD-1 52 56 4675 4679 I-treatment
) 56 57 4679 4680 I-treatment
, 57 58 4680 4681 O
anti 59 63 4682 4686 B-treatment
- 63 64 4686 4687 I-treatment
programmed 64 74 4687 4697 I-treatment
cell 75 79 4698 4702 I-treatment
death 80 85 4703 4708 I-treatment
- 85 86 4708 4709 I-treatment
ligand 86 92 4709 4715 I-treatment
1 93 94 4716 4717 I-treatment
( 95 96 4718 4719 I-treatment
PD 96 98 4719 4721 I-treatment
- 98 99 4721 4722 I-treatment
L1 99 101 4722 4724 I-treatment
) 101 102 4724 4725 I-treatment
, 102 103 4725 4726 O
or 104 106 4727 4729 O
anti 107 111 4730 4734 B-treatment
- 111 112 4734 4735 I-treatment
programmed 112 122 4735 4745 I-treatment
cell 123 127 4746 4750 I-treatment
death 128 133 4751 4756 I-treatment
- 133 134 4756 4757 I-treatment
ligand 134 140 4757 4763 I-treatment
2 141 142 4764 4765 I-treatment
( 143 144 4766 4767 I-treatment
PD 144 146 4767 4769 I-treatment
- 146 147 4769 4770 I-treatment
L2 147 149 4770 4772 I-treatment
) 149 150 4772 4773 I-treatment
agent 151 156 4774 4779 I-treatment

Received 0 8 4780 4788 O
a 9 10 4789 4790 O
live 11 15 4791 4795 B-treatment
vaccine 16 23 4796 4803 I-treatment
within 24 30 4804 4810 O
30 31 33 4811 4813 B-upper_bound
days 34 38 4814 4818 I-upper_bound
of 39 41 4819 4821 O
planned 42 49 4822 4829 O
start 50 55 4830 4835 O
of 56 58 4836 4838 O
study 59 64 4839 4844 O
therapy 65 72 4845 4852 B-treatment

Serum 0 5 4853 4858 B-clinical_variable
creatinine 6 16 4859 4869 I-clinical_variable
= 17 18 4870 4871 O
< 18 19 4871 4872 O
1.5 20 23 4873 4876 B-upper_bound
X 24 25 4877 4878 I-upper_bound
upper 26 31 4879 4884 I-upper_bound
limit 32 37 4885 4890 I-upper_bound
of 38 40 4891 4893 I-upper_bound
normal 41 47 4894 4900 I-upper_bound
( 48 49 4901 4902 I-upper_bound
ULN 49 52 4902 4905 I-upper_bound
) 52 53 4905 4906 I-upper_bound
OR 54 56 4907 4909 O
measured 57 65 4910 4918 O
or 66 68 4919 4921 O
calculated 69 79 4922 4932 O
creatinine 80 90 4933 4943 O
clearance 91 100 4944 4953 O
( 101 102 4954 4955 O
glomerular 102 112 4955 4965 B-clinical_variable
filtration 113 123 4966 4976 I-clinical_variable
rate 124 128 4977 4981 I-clinical_variable
[ 129 130 4982 4983 I-clinical_variable
GFR 130 133 4983 4986 I-clinical_variable
] 133 134 4986 4987 I-clinical_variable
can 135 138 4988 4991 O
also 139 143 4992 4996 O
be 144 146 4997 4999 O
used 147 151 5000 5004 O
in 152 154 5005 5007 O
place 155 160 5008 5013 O
of 161 163 5014 5016 O
creatinine 164 174 5017 5027 O
or 175 177 5028 5030 O
creatinine 178 188 5031 5041 B-clinical_variable
clearance 189 198 5042 5051 I-clinical_variable
rate 199 203 5052 5056 I-clinical_variable
[ 204 205 5057 5058 I-clinical_variable
CrCl 205 209 5058 5062 I-clinical_variable
] 209 210 5062 5063 I-clinical_variable
) 210 211 5063 5064 I-clinical_variable
> 212 213 5065 5066 O
= 213 214 5066 5067 O
35 215 217 5068 5070 B-lower_bound
mL 218 220 5071 5073 I-lower_bound
/ 220 221 5073 5074 I-lower_bound
min 221 224 5074 5077 I-lower_bound
for 225 228 5078 5081 O
subject 229 236 5082 5089 O
with 237 241 5090 5094 O
creatinine 242 252 5095 5105 B-clinical_variable
levels 253 259 5106 5112 I-clinical_variable
> 260 261 5113 5114 O
1.5 262 265 5115 5118 B-lower_bound
X 266 267 5119 5120 I-lower_bound
institutional 268 281 5121 5134 I-lower_bound
ULN 282 285 5135 5138 I-lower_bound

Serum 0 5 5139 5144 B-clinical_variable
total 6 11 5145 5150 I-clinical_variable
bilirubin 12 21 5151 5160 I-clinical_variable
= 22 23 5161 5162 O
< 23 24 5162 5163 O
1.5 25 28 5164 5167 B-upper_bound
X 29 30 5168 5169 I-upper_bound
ULN 31 34 5170 5173 I-upper_bound
OR 35 37 5174 5176 O
direct 38 44 5177 5183 B-clinical_variable
bilirubin 45 54 5184 5193 I-clinical_variable
= 55 56 5194 5195 O
< 56 57 5195 5196 O
ULN 58 61 5197 5200 O
for 62 65 5201 5204 O
subjects 66 74 5205 5213 O
with 75 79 5214 5218 O
total 80 85 5219 5224 B-clinical_variable
bilirubin 86 95 5225 5234 I-clinical_variable
levels 96 102 5235 5241 I-clinical_variable
> 103 104 5242 5243 O
1.5 105 108 5244 5247 B-lower_bound
ULN 109 112 5248 5251 I-lower_bound

